New Horizon Health Ltd Ordinary Shares 06606
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- HKD 17.62
- Day Range
- HKD 13.76–17.80
- 52-Week Range
- HKD 13.76–32.55
- Bid/Ask
- HKD 14.14 / HKD 14.18
- Market Cap
- HKD 6.34 Bil
- Volume/Avg
- 5.3 Mil / 1.4 Mil
Key Statistics
- Price/Earnings (Normalized)
- 102.36
- Price/Sales
- 4.21
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
New Horizon Health Ltd is engaged in early cancer screening and in-home testing in China. The company has an early detection and cancer screening-focused pipeline of five products and product candidates with an emphasis on colorectal cancer screening. The company focuses on cancer prevention and cure through screening and early detection. It generates maximum revenue from ColoClear and Pupu Tube products.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 1,041
- Website
- https://ir.newhorizonbio.com
Comparables
Valuation
|
Metric
|
06606
|
TIHE
|
300642
|
|---|---|---|---|
Price/Earnings (Normalized) | 102.36 | — | 42.93 |
Price/Book Value | 2.01 | — | 1.38 |
Price/Sales | 4.21 | — | 4.06 |
Price/Cash Flow | — | — | 13.25 |
Price/Earnings
06606
TIHE
300642
Financial Strength
|
Metric
|
06606
|
TIHE
|
300642
|
|---|---|---|---|
Quick Ratio | 10.14 | — | 5.66 |
Current Ratio | 10.77 | — | 7.12 |
Interest Coverage | −1.14 | — | 105.34 |
Quick Ratio
06606
TIHE
300642
Profitability
|
Metric
|
06606
|
TIHE
|
300642
|
|---|---|---|---|
Return on Assets (Normalized) | 2.20% | — | — |
Return on Equity (Normalized) | 2.63% | — | — |
Return on Invested Capital (Normalized) | 2.17% | — | — |
Return on Assets
06606
TIHE
300642
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Zqncrvp | Pydxls | $179.0 Bil | |
SYK
| Stryker Corp | Lgtyqvnl | Ppjkk | $129.3 Bil | |
BSX
| Boston Scientific Corp | Vwplzjq | Cydtrd | $111.0 Bil | |
MDT
| Medtronic PLC | Lmyxksmdk | Grrwhl | $107.7 Bil | |
EW
| Edwards Lifesciences Corp | Fjgyhxpwl | Nqwdgbv | $52.9 Bil | |
DXCM
| DexCom Inc | Khkjwtxmr | Kjps | $45.6 Bil | |
PHG
| Koninklijke Philips NV ADR | Ppwpdqbl | Ljglz | $25.0 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Nmzgqvxt | Gmvw | $23.3 Bil | |
STE
| Steris PLC | Qfpgyny | Pxhdgn | $22.6 Bil | |
ALGN
| Align Technology Inc | Dwnpffl | Mrzkndc | $19.2 Bil |